Literature DB >> 8856081

The purification and characterization of the catalytic domain of Src expressed in Schizosaccharomyces pombe. Comparison of unphosphorylated and tyrosine phosphorylated species.

A Weijland1, G Neubauer, S A Courtneidge, M Mann, R K Wierenga, G Superti-Furga.   

Abstract

The catalytic domain of chicken Src including the C-terminal tail (Src-CD), has been expressed in Schizosaccharomyces pombe and purified to homogeneity. The expressed protein is a mixture of unphosphorylated (80%) and mono-phosphorylated (20%) species, that can be separated from each other by Mono Q chromatography. By a novel mass spectrometric method that utilizes parent ion scans of unseparated peptide mixtures, we found that the mono-phosphorylated form is phosphorylated either at Tyr416 or at Tyr436. The stability of Src-CD is comparable to the wild-type protein. Src-CD auto-phosphorylates and efficiently phosphorylates substrate peptides and proteins. Auto-phosphorylation occurs by an intermolecular mechanism and is completely inhibited by an excess of substrate peptide. Kinetic measurements for two exogenous substrates, the Src substrate peptide (AEEEIYGEFEAKKKK) and denatured enolase, showed that the overall activity (kcat) of the Src-CD molecule is about 10 times higher than that of wild-type Src. The kcat values for phosphorylation of the Src substrate peptide are similar for the unphosphorylated and monophosphorylated Src-CD (50 min-1), but the apparent K(m) values differ significantly (approximately 3 microM and 10 microM, respectively). Therefore, at low substrate concentrations in vitro the mono-phosphorylated form is more active, in agreement with the importance of Tyr416 for in vivo activity. The apparent K(m) values of the mono-phosphorylated Src-CD and wild-type Src for the Src substrate peptide and enolase are similar, indicating that, under these conditions, the kinase domain is mainly responsible for substrate binding.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8856081     DOI: 10.1111/j.1432-1033.1996.0756h.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  9 in total

1.  Expression and purification of Src-family kinases for solution NMR studies.

Authors:  Andrea Piserchio; David Cowburn; Ranajeet Ghose
Journal:  Methods Mol Biol       Date:  2012

2.  Structural characterization of autoinhibited c-Met kinase produced by coexpression in bacteria with phosphatase.

Authors:  Weiru Wang; Adhirai Marimuthu; James Tsai; Abhinav Kumar; Heike I Krupka; Chao Zhang; Ben Powell; Yoshihisa Suzuki; Hoa Nguyen; Maryam Tabrizizad; Catherine Luu; Brian L West
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-28       Impact factor: 11.205

3.  Identification of N-terminal lobe motifs that determine the kinase activity of the catalytic domains and regulatory strategies of Src and Csk protein tyrosine kinases.

Authors:  Kezhen Huang; Yue-Hao Wang; Alex Brown; Gongqin Sun
Journal:  J Mol Biol       Date:  2009-03-06       Impact factor: 5.469

4.  Src regulated by C-terminal phosphorylation is monomeric.

Authors:  A Weijland; J C Williams; G Neubauer; S A Courtneidge; R K Wierenga; G Superti-Furga
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

5.  High yield bacterial expression of active c-Abl and c-Src tyrosine kinases.

Authors:  Markus A Seeliger; Matthew Young; M Nidanie Henderson; Patricia Pellicena; David S King; Arnold M Falick; John Kuriyan
Journal:  Protein Sci       Date:  2005-10-31       Impact factor: 6.725

6.  Global impact of oncogenic Src on a phosphotyrosine proteome.

Authors:  Weifeng Luo; Robbert J Slebos; Salisha Hill; Ming Li; Jan Brábek; Ramars Amanchy; Raghothama Chaerkady; Akhilesh Pandey; Amy-Joan L Ham; Steven K Hanks
Journal:  J Proteome Res       Date:  2008-06-19       Impact factor: 4.466

7.  Optimized bacterial expression and purification of the c-Src catalytic domain for solution NMR studies.

Authors:  Andrea Piserchio; Ranajeet Ghose; David Cowburn
Journal:  J Biomol NMR       Date:  2009-04-28       Impact factor: 2.835

8.  A conserved isoleucine maintains the inactive state of Bruton's tyrosine kinase.

Authors:  Scott E Boyken; Nikita Chopra; Qian Xie; Raji E Joseph; Thomas E Wales; D Bruce Fulton; John R Engen; Robert L Jernigan; Amy H Andreotti
Journal:  J Mol Biol       Date:  2014-09-02       Impact factor: 5.469

9.  The IRAK homolog Pelle is the functional counterpart of IκB kinase in the Drosophila Toll pathway.

Authors:  Jessica Daigneault; Liv Klemetsaune; Steven A Wasserman
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.